SCHEMBL24310308

SCHEMBL24310308

Clc1cc(-c2ccccc2)nc(NSc2ccccc2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.50
HSP90AA1 P07900 1/20 0.50
HSP90AB1 P08238 1/20 0.50
AGTR1 P30556 4/20 0.45
MAPT P10636 4/20 0.45
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 3/20 0.44
MEN1 O00255 2/20 0.44
ALDH1A1 P00352 2/20 0.44
HPGD P15428 2/20 0.44
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
ADORA3 P0DMS8 3/20 0.40
HRH4 Q9H3N8 1/20 0.40
ADORA1 P30542 7/20 0.40
POLB P06746 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
ADORA2A P29274 2/20 0.37
GAA P10253 2/20 0.37
ADORA2B P29275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11289134 0.89 AGTR1 (0.56) AGTR1MAPTTDP1L3MBTL1MEN1
SCHEMBL24309748 0.87 L3MBTL1 (0.38) KDM4EHSP90AA1HSP90AB1MAPTL3MBTL1
SCHEMBL24309613 0.80 MAPT (0.44) KDM4EAGTR1MAPTTDP1L3MBTL1
SCHEMBL24309283 0.79 TDP1 (0.46) KDM4EAGTR1MAPTTDP1L3MBTL1
SCHEMBL3473073 0.77 TDP1 (0.76) KDM4EHSP90AA1HSP90AB1AGTR1MAPT
SCHEMBL24309752 0.77 MAPK1 (0.57) AGTR1MAPTTDP1L3MBTL1MEN1
SCHEMBL24309335 0.76 HPGD (0.37) MAPTL3MBTL1MEN1ALDH1A1HPGD
SCHEMBL24309268 0.76 BPTF (0.44) KDM4EAGTR1MAPTTDP1L3MBTL1
SCHEMBL3289041 0.76 MAPT (0.55) KDM4EHSP90AA1HSP90AB1AGTR1MAPT
SCHEMBL24287409 0.75 MEN1 (0.58) KDM4EHSP90AA1HSP90AB1AGTR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed